New Market Research Report: Pharmaceutical & Healthcare Annual Deals Analysis 2011

April 10, 2011 - PRLog -- Pharmaceutical & Healthcare Annual Deals Analysis 2011

Summary

GlobalData's "Pharmaceutical & Healthcare Annual Deals Analysis 2011" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on Partnerships, Licensing Agreements, M&As, Equity/Debt Offerings, Private Equity and Venture Financing transactions registered in the pharmaceutical and healthcare industry in 2010. The report presents detailed comparative data on the number of deals and their value in the past five years categorized into deal types, segments, and geographies. Additionally, the report provides information on the top venture capital and advisory firms in the pharmaceutical and healthcare industry.

Data presented in this report is derived from GlobalData's proprietary in-house Pharma eTrack deals database and primary and secondary research.

Scope

* Analysis of the market trends for the pharmaceutical industry in the global arena.
* Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
* Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
* Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
* Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
* Analysis of partnership and licensing deals based on clinical stage of development of products.
* Summary of the pharmaceutical deals globally in the last five years
* Information on the top deals happened in the pharmaceutical industry.
* Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
* League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.


Reasons to buy

* Enhance your decision making capability in a more rapid and time sensitive manner.
* Find out the major deal performing segments for investments in your industry.
* Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
* Identify companies that are aggressively looking to raise capital in the market
* Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
* Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
* Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
* Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
* Identify growth segments and opportunities in each region within the industry.
* Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.


For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/148784_pharmaceutical_healthca...


Partial Table of Contents:

1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Pharmaceutical & Healthcare, Global, Deals Summary
2.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2010
2.1.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2010 by Quarter
2.2 Pharmaceutical & Healthcare, Global, by Type, Number of Deals and Deal Values, 2010
2.3 Pharmaceutical & Healthcare, Global, Top Deals, 2010
2.4 Pharmaceutical & Healthcare, Top Deals, Global, Summaries, 2010
2.4.1 Novartis Completes Acquisition Of Additional 52% Stake In Alcon From Nestle
2.4.2 Sanofi-Aventis To Raise Its Bid For The Acquisition Of Genzyme
2.4.3 Novartis Receives Alcon's Board Approval For The Acquisition Of Remaining 23% Stake
2.4.4 Merck Completes The Acquisition Of Millipore
2.4.5 Novartis Completes Public Offering Of Senior Notes For $5000m
2.4.6 HCA Refiles Registration Statement For An Initial Public Offering Of $4,600m
2.4.7 BASF Acquires Cognis From Permira And Goldman Sachs
2.4.8 Astellas Pharma Acquires OSI Pharmaceuticals
2.4.9 Reckitt Benckiser Completes Acquisition Of SSL International
2.4.10 Carlyle Group Completes Acquisition Of NBTY
3 Pharmaceutical & Healthcare, Global, Top Deal Makers, 2010
4 Pharmaceutical & Healthcare, Global, Deal Summary, by Type
4.1 Pharmaceutical & Healthcare, Global, M&A, 2010
4.1.1 Pharmaceutical & Healthcare, Global, M&A, 2010 by Quarter
4.1.2 Top M&A Deals in 2010
4.1.3 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2010
4.2 Pharmaceutical & Healthcare, Global, Equity Offering Deals, 2010
4.2.1 Pharmaceutical & Healthcare, Global, Equity Offering Deals, 2010 by Quarter
4.2.2 Pharmaceutical & Healthcare, Global, IPO Deals, 2010
4.2.3 Pharmaceutical & Healthcare, Global, Secondary Offerings Deals, 2010
4.2.4 Pharmaceutical & Healthcare, Global, PIPE Deals, 2010
4.2.5 Pharmaceutical & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2010
4.3 Pharmaceutical & Healthcare, Global, Debt Offering Deals, 2010
4.3.1 Pharmaceutical & Healthcare, Global Debt Offerings, 2010 by Quarter
4.3.2 Pharmaceutical & Healthcare, Global, Public Debt Offerings, 2010
4.3.3 Pharmaceutical & Healthcare, Global, Private Debt Placements, 2010
4.3.4 Pharmaceutical & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2010

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1487...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.